KR960037049A - Angiogenesis inhibitors containing derivatives of kenodeoxycholic acid - Google Patents

Angiogenesis inhibitors containing derivatives of kenodeoxycholic acid Download PDF

Info

Publication number
KR960037049A
KR960037049A KR1019950009439A KR19950009439A KR960037049A KR 960037049 A KR960037049 A KR 960037049A KR 1019950009439 A KR1019950009439 A KR 1019950009439A KR 19950009439 A KR19950009439 A KR 19950009439A KR 960037049 A KR960037049 A KR 960037049A
Authority
KR
South Korea
Prior art keywords
kenodeoxycholic acid
angiogenesis inhibitors
containing derivatives
inhibitors containing
angiogenesis
Prior art date
Application number
KR1019950009439A
Other languages
Korean (ko)
Other versions
KR0156226B1 (en
Inventor
김규원
서홍석
이호영
김태형
허희경
Original Assignee
서홍석
김규원
서치영
주식회사 대웅제약
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 서홍석, 김규원, 서치영, 주식회사 대웅제약 filed Critical 서홍석
Priority to KR1019950009439A priority Critical patent/KR0156226B1/en
Publication of KR960037049A publication Critical patent/KR960037049A/en
Application granted granted Critical
Publication of KR0156226B1 publication Critical patent/KR0156226B1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

본 발명은 하기 일반식들로 표시되는 케노데옥시콜리산 유도체의 1종을 유효성분으로서, 혈관 형성 억제에 유효한 양으로 함유하는 혈관 형성 억제제를 제공한다.The present invention provides an angiogenesis inhibitor containing one kind of the kenodeoxycholic acid derivative represented by the following general formulas as an active ingredient in an amount effective to inhibit angiogenesis.

Description

케노데옥시콜린산의 유도체를 함유하는 혈관형성 억제제Angiogenesis inhibitors containing derivatives of kenodeoxycholic acid

본 내용은 요부공개 건이므로 전문내용을 수록하지 않았음As this is a public information case, the full text was not included.

Claims (1)

하기 일반식들로 표시되는 케노데옥시콜린산 유도체의 1종을 유효성분으로서, 혈관 형성 억제에 유효한 양으로 함유하는 혈관 형성 억제제.An angiogenesis inhibitor containing one kind of kenodeoxycholic acid derivative represented by the following general formula as an active ingredient in an amount effective to inhibit angiogenesis. ※ 참고사항 : 최초출원 내용에 의하여 공개하는 것임.※ Note: The disclosure is based on the initial application.
KR1019950009439A 1995-04-21 1995-04-21 Vascularization-inhibitor containing cdca-derivatives KR0156226B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
KR1019950009439A KR0156226B1 (en) 1995-04-21 1995-04-21 Vascularization-inhibitor containing cdca-derivatives

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
KR1019950009439A KR0156226B1 (en) 1995-04-21 1995-04-21 Vascularization-inhibitor containing cdca-derivatives

Publications (2)

Publication Number Publication Date
KR960037049A true KR960037049A (en) 1996-11-19
KR0156226B1 KR0156226B1 (en) 1998-11-16

Family

ID=19412660

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019950009439A KR0156226B1 (en) 1995-04-21 1995-04-21 Vascularization-inhibitor containing cdca-derivatives

Country Status (1)

Country Link
KR (1) KR0156226B1 (en)

Also Published As

Publication number Publication date
KR0156226B1 (en) 1998-11-16

Similar Documents

Publication Publication Date Title
KR910010239A (en) Radiation-sensitive resin composition
RS49673B (en) Nitric oxide synthase inhibitors
KR960700045A (en) Angiogenesis Inhibitors and Novel Compounds
KR950002588A (en) Hydrogen Peroxide Composition
KR940003542A (en) External skin preparation
KR850002377A (en) Insecticide composition
KR950703941A (en) Nitrogen monoxide synthase inhibitor (NITROGEN MONOXIDE SYNTHESIS INHIBITOR)
KR880012219A (en) p-hydroxy cinnamic derivatives and melanin inhibitors containing the same
KR890011588A (en) Liver fibrosis inhibitor
ES2189736T3 (en) DERIVATIVES OF BENZAMIDE AND MEDICINES CONTAINING THEM.
KR960037049A (en) Angiogenesis inhibitors containing derivatives of kenodeoxycholic acid
KR960037050A (en) Angiogenesis inhibitors containing derivatives of ursodeoxycholic acid
KR960700245A (en) Methotrexate derivative [METHOTREXATE DERIVATIVE]
KR900011470A (en) External preparation
FI963168A (en) New Indan-2-Mercaptoacetylamide Disulfide Derivatives Useful as Enkephalinase Inhibitors
KR850005228A (en) Aminoalkanosephosphonic acid and its derivatives as fungicides
KR920702685A (en) 4,6-O-hydroxyphosphorylglucosamine derivative
KR960703595A (en) ANTIDEPRESSANT
KR920008012A (en) Triazole derivatives
KR900016144A (en) 4-imidazoline derivative
KR890005081A (en) Novel 2-oxyaminoalkylidene-cyclohexane-1,3-dione derivatives having herbicidal effect
KR910005761A (en) Herbicide composition
KR920007530A (en) Herbicide composition
KR900003201A (en) Peptides and Antidementants
KR960037048A (en) Collagenase Expression Inhibitors Containing Ursolic Acid

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20130327

Year of fee payment: 16

FPAY Annual fee payment

Payment date: 20140306

Year of fee payment: 17

EXPY Expiration of term